Evidence map›Paper›PMID 42681186›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Phage Display In Vivo: Protocols for Identifying Brain-Targeting Peptides in Mouse Models of Neurodegeneration.

Roberta Aquino Martins, Luís Felipe Galvão Valdivia, Andressa Godoy Amaral, Daniella Sabino Battagello, Ricardo José Giordano

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Roberta Aquino MartinsBiochemistry Department, Institute of Chemistry, University of Sao Paulo, São Paulo, SP, Brazil.
Luís Felipe Galvão ValdiviaBiochemistry Department, Institute of Chemistry, University of Sao Paulo, São Paulo, SP, Brazil.
Andressa Godoy AmaralBiochemistry Department, Institute of Chemistry, University of Sao Paulo, São Paulo, SP, Brazil.
Daniella Sabino BattagelloBiochemistry Department, Institute of Chemistry, University of Sao Paulo, São Paulo, SP, Brazil.
Ricardo José GiordanoBiochemistry Department, Institute of Chemistry, University of Sao Paulo, São Paulo, SP, Brazil. giordano@iq.usp.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vivo phage display is a versatile strategy for an unbiased identification of peptide ligands that selectively interact with molecular targets, in vitro, in cell, and in vivo, in living organisms. In a previous study, we validated this technology to identify a brain targeting peptide. Here, we detail the protocol for selection using phage display in vivo of peptide targeting the mouse brain, in health and disease. Given the need of alternative models to study degenerative disease, such as Alzheimer's disease, we elected the murine model of neuroinflammation and neurodegeneration as an example. This model utilizes the stereotaxic intracerebroventricular administration of streptozotocin (STZ) to induce neuroinflammation, an event that recapitulates key pathological hallmarks of Alzheimer's disease. Following the establishment of the disease model, a randomized phage display peptide library-a collection of billions of phages, each displaying a different peptide sequence on their surface-is administered intravenously into healthy and diseased mice. This allows selective interaction of individual phage with vascular, tissue-specific receptors under physiological or in a pathological condition with which a compromised blood-brain barrier may alter brain homeostasis. After systemic circulation, animals undergo perfusion and organs are harvested for phage recovery and amplification, followed by iterative rounds of biopanning to enrich for high-affinity ligands. This approach offers a robust platform for the discovery of novel diagnostic probes, therapeutic ligands, and molecular markers relevant to brain biology, in health, neuroinflammation and neurodegeneration. Most importantly, the adaptability of this technology enables its application across diverse murine models of human disease, thereby establishing an easy and systematic approach to facilitate the translation of laboratory discoveries into a wide spectrum of human diseases.

Indexed as

BrainCell Surface Display TechniquesNeurodegenerative DiseasesPeptide LibraryPeptidesAlzheimer DiseaseAnimalsDisease Models, AnimalMiceStreptozocinPeptide LibraryPeptidesStreptozocinBrain-targeting peptidesIn vivo phage displayNeurodegeneration

Identifiers

PMID42681186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.